CDH1 and neoplasm: In particular, miR-146b targets the IL-1 receptor-associated kinase 1 (IRAK1), in which its inhibition is correlated with increased PTC cell proliferation, tumor invasiveness, and aggressiveness, probably due to the deregulation of the E-cadherin-mediated EMT (13, 14).